Cymab ApS

Cymab ApS (CVR number: 39859173) is a company from KØBENHAVN. The company recorded a gross profit of -1206 kDKK in 2023. The operating profit was -3177.8 kDKK, while net earnings were -2580.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was -26.1 %, which can be considered poor and Return on Equity (ROE) was -48.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -59.1 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Cymab ApS's liquidity measured by quick ratio was 3.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.